Demand for hand transplants low due to cost, need for drugs

12/11/2012 | Philadelphia Inquirer, The

So few patients have taken advantage of advances in hand transplantation technology that some medical centers have yet to perform their first procedure two years after launching programs. Costs, patient selection criteria and the prospect of lifelong treatment with immunosuppressants deter possible candidates, experts say. Researchers are seeking ways to prevent organ rejection that use fewer drugs.

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD